(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2.51%40.34B | 4.04%29.54B | 6.28%18.87B | 5.77%8.96B | 71.84%39.35B | 71.87%28.39B | 68.52%17.76B | 71.18%8.47B | 38.50%22.9B | 39.84%16.52B |
Operating income | 2.51%40.34B | 4.04%29.54B | 6.28%18.87B | 5.77%8.96B | 71.84%39.35B | 71.87%28.39B | 68.52%17.76B | 71.18%8.47B | 38.50%22.9B | 39.84%16.52B |
Cost of sales | 3.54%-23.97B | 2.56%-17.47B | 0.12%-11.32B | 0.39%-5.44B | -69.76%-24.85B | -71.78%-17.93B | -70.29%-11.33B | -75.42%-5.46B | -42.38%-14.64B | -41.21%-10.44B |
Operating expenses | 3.54%-23.97B | 2.56%-17.47B | 0.12%-11.32B | 0.39%-5.44B | -69.76%-24.85B | -71.78%-17.93B | -70.29%-11.33B | -75.42%-5.46B | -42.38%-14.64B | -41.21%-10.44B |
Gross profit | 12.86%16.37B | 15.35%12.07B | 17.56%7.56B | 16.94%3.53B | 75.51%14.51B | 72.01%10.46B | 65.48%6.43B | 64.01%3.01B | 32.14%8.27B | 37.54%6.08B |
Selling expenses | 4.18%-701.03M | 6.14%-521.22M | 0.60%-353.47M | -1.55%-175.85M | -4.67%-731.59M | -11.69%-555.3M | -0.10%-355.61M | -9.22%-173.18M | -18.78%-698.97M | -21.03%-497.16M |
Administrative expenses | -1.74%-2.99B | 1.91%-2.06B | -1.43%-1.33B | -8.16%-669.39M | -30.63%-2.94B | -36.46%-2.1B | -31.40%-1.31B | -27.31%-618.87M | -20.53%-2.25B | -16.10%-1.54B |
Research and development expenses | 10.74%-1.44B | 5.83%-1.03B | -1.50%-667.05M | -27.59%-357.3M | -71.29%-1.61B | -69.09%-1.09B | -62.50%-657.2M | -36.89%-280.04M | -35.91%-942.24M | -35.58%-644.21M |
Impairment and provision | -43.99%-357.9M | -86.95%-175.66M | -146.09%-144.58M | 82.70%-6.29M | -686.22%-248.56M | -305.71%-93.96M | -171.44%-58.75M | -141.32%-36.36M | 44.51%-31.62M | -101.16%-23.16M |
-Goodwill impairment | 62.22%-49.61M | ---- | ---- | ---- | ---131.29M | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | -162.87%-308.29M | -86.95%-175.66M | -146.09%-144.58M | 82.70%-6.29M | -270.96%-117.28M | -305.71%-93.96M | -171.44%-58.75M | -141.32%-36.36M | -150.38%-31.62M | -101.16%-23.16M |
Special items of operating profit | 24.61%2.31B | -29.58%1.7B | -7.94%1.5B | 83.38%393.74M | -3.44%1.86B | 140.50%2.41B | 72.23%1.63B | -72.66%214.72M | 215.36%1.92B | 32.66%1B |
Operating profit | 21.86%13.19B | 10.50%9.99B | 15.63%6.57B | 27.79%2.71B | 72.88%10.82B | 106.19%9.04B | 85.93%5.68B | 20.57%2.12B | 71.25%6.26B | 48.27%4.38B |
Financing cost | -21.11%-193.58M | -37.24%-154.93M | -49.46%-101.07M | -124.69%-64.17M | -24.55%-159.84M | -15.62%-112.89M | 1.79%-67.62M | 18.40%-28.56M | 34.54%-128.33M | 38.20%-97.64M |
Share of profits of associates | 33.23%-35.08M | 45.34%-58.39M | -7.96%-76.47M | 52.39%-45.81M | 43.00%-52.53M | -783.64%-106.81M | -132.60%-70.84M | -294.97%-96.23M | -19.95%-92.16M | 120.56%15.62M |
Share of profit from joint venture company | -618.83%-32.48M | 1,625.56%6.8M | 436.61%7.7M | 256.28%8.31M | 124.92%6.26M | 97.68%-446K | 106.43%1.43M | 157.55%2.33M | -80.54%-25.13M | -31.04%-19.25M |
Earning before tax | 21.77%12.93B | 10.92%9.78B | 15.42%6.4B | 30.53%2.61B | 76.52%10.62B | 105.93%8.82B | 74.24%5.54B | 17.85%2B | 78.54%6.02B | 58.14%4.28B |
Tax | -24.24%-2.13B | -18.99%-1.63B | -20.01%-1.04B | -23.44%-423.07M | -95.06%-1.72B | -97.67%-1.37B | -77.39%-865.2M | -81.54%-342.72M | -129.60%-879.66M | -116.34%-694.43M |
After-tax profit from continuing operations | 21.29%10.8B | 9.43%8.15B | 14.57%5.36B | 32.00%2.19B | 73.34%8.9B | 107.53%7.45B | 73.67%4.68B | 9.88%1.66B | 71.99%5.14B | 50.32%3.59B |
Earning after tax | 21.29%10.8B | 9.43%8.15B | 14.57%5.36B | 32.00%2.19B | 73.34%8.9B | 107.53%7.45B | 73.67%4.68B | 9.88%1.66B | 71.99%5.14B | 50.32%3.59B |
Minority profit | 21.17%107.72M | 5.15%72.24M | 9.69%43.78M | 35.93%17.68M | 129.17%88.9M | 164.07%68.7M | 133.50%39.91M | 78.16%13M | 49.11%38.79M | 38.77%26.02M |
Profit attributable to shareholders | 21.29%10.69B | 9.47%8.08B | 14.61%5.31B | 31.97%2.17B | 72.91%8.81B | 107.12%7.38B | 73.29%4.64B | 9.54%1.64B | 72.19%5.1B | 50.41%3.56B |
Basic earnings per share | 20.93%3.64 | 9.13%2.75 | 13.84%1.81 | 32.14%0.74 | 72.00%3.01 | 106.56%2.52 | 72.83%1.59 | 7.69%0.56 | 65.09%1.75 | 41.86%1.22 |
Diluted earnings per share | 28.01%3.61 | 18.70%2.73 | 20.95%1.79 | 35.85%0.72 | 63.01%2.82 | 90.08%2.3 | 62.64%1.48 | 3.92%0.53 | 64.76%1.73 | 42.35%1.21 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data